Effect of Homoeopathic Medicine Gnaphalium in the Treatment of Lowback pain extending to leg

A Prospective Clinical Case series Study of Sciatica patients treated with Gnaphalium polycephalum.Q - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059226

Enrollment

Registered

2023-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M544- Lumbago with sciatica Health Condition 2: M543- Sciatica

Interventions

Intervention1: Gnaphalium polycephalum.Q (Mother Tincture): 20 Drops orally with 15 ml of water - Morning and Night for 90 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Sciatica Patients (ICD 11 - ME84.3)

Exclusion criteria

Exclusion criteria: Degenerative conditions of spine - Vertebral osteochondrosis, Spondylosis, Facet joints, Spondylolysis & spondylolisthesis, Degenerative stenosis, Known Lesions of sciatic nerve Chronic neuropathic pain by any Specific Diseases

Design outcomes

Primary

Measure	Time frame
Scoring tool based on model for clinical assessment items and corresponding predicted probability of sciatica QuestionnaireTimepoint: 90 Days	—

Secondary

Measure	Time frame
A modified Roland-Morris disability scale for the assessment of sciaticaTimepoint: 90 Days	—

Countries

India

Contacts

Public ContactDr H Venkatesan

Vinayaka Missions Homoeopathic Medical College and Hospital Salem

venkathompath@gmail.com9865134561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026